Perspectives on pandemics: A research agenda

Journal of Infectious Diseases

Volumn 176, Issue SUPPL. 1, 1997, Pages

  Kilbourne, Edwin D ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; EPIDEMIC; HISTORY; INFLUENZA; INFLUENZA VACCINATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; VIRUS CHARACTERIZATION; VIRUS STRAIN; VIRUS VIRULENCE;

EID: 0030850759     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514171     Document Type: Conference Paper

References (23)

1. Kilbourne ED. Influenza pandemics in perspective. JAMA 1977;237: 1225-8.
2. Kilbourne ED. Op-ed page, New York Times, 13 February 1976:33.
3. Federal Interagency Working Group. Prevention and control of influenza in the United States: preparing for the next pandemic. Draft, 1997.
4. Slepushkin AN, The effect of a previous attack of Al influenza on susceptibility to A2 virus during the 1957 outbreak. Bull WHO 1959;20:297-301.
5. Sonoguchi T, Naito H, Hara M, et al. Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J Infect Dis 1985;151:81-8.
6. Davenport FM. Reflections on the epidemiology of myxovirus infections. Med Microbiol Immunol 1977;164:69-76.
7. Hirsch A. Acute infective diseases. Handbook of geographical and historical pathology. Vol. I. (Creighton C., trans.). London: New Sydenham Society, 1883.
8. Francis T Jr. Vaccination against influenza, Bull WHO 1953;8:725-41.
9. Kilbourne ED, Loge JP. Influenza A prime: a clinical study of an epidemic caused by a new strain of virus. Ann Intern Med 1950;33:371-9.
10. Loge JP, Kilbourne ED. Penicillin treatment of streptococcal pharyngitis. Ann Intern Med 1948;29:698-714.
11. Meyer HM Jr, Hopps HE, Parkman PD, Ennis FA. Review of existing vaccines for influenza. Am J Clin Pathol 1977;70:146-52.
12. Dowdle WR, Coleman MT, Hall EC, Knez V. Properties of the Hong Kong influenza virus. 2. Antigenic relationship of the Hong Kong virus haemagglutinin to that of other human influenza A viruses. Bull WHO 1969;41:419-24.
13. Semple AB. Epidemiology of the influenza epidemic in Liverpool in 1950-1951. Proc R Soc Med 1951;44:794-6.
14. Dowdle WR, Coleman MT, Gregg MB. Natural history of influenza type A in the United States, 1957-1972. Progr Med Virol 1974;17:91-135.
15. Kilbourne ED. Influenza. New York: Plenum Publishing, 1974:19.
16. Gill PW, Babbage NF, Gunton PE, Flower W, Garrett DA. Did the Asian virus protect us from Hong Kong influenza? Med J Aust 1971;2:53-4.
17. Rodin AT. National experience with Hong Kong influenza in the United Kingdom, 1968-69. Bull WHO 1969;41:375-80.
18. Eickhoff TC, Meiklejohn G. Protection against Hong Kong influenza by adjuvant vaccine containing A2/Ann Arbor/67. Bull WHO 1969;41: 562-3.
19. Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957-58. II. Pulmonary complications of influenza. J Clin Invest 1959;38:213-65.
20. Kilbourne ED. The severity of influenza as a reciprocal of host susceptibility. In: Ciba Foundation Study Group No. 4. Virus virulence and pathogenicity. Wolstenholme GEW, O'Connor CM, eds. Boston: Little Brown, 1960;58-77.
21. Schleiblauer H, Reinacher M, Tashiro M, Rott R. Interactions between bacteria and influenza A virus in the development of influenza pneumonia. J Infect Dis 1992;166:783-91.
22. Kilbourne ED. Recombination of influenza A viruses of human and animal origin. Science 1968;160:74-6.
23. Kilbourne ED, Johansson BE, Grajower B. Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase. Proc Natl Acad Sci USA 1990;87:786-90.